基于生理药代动力学的佛手柑内酯与6,7-二羟基佛手柑内酯模型描述CYP3A4介导的葡萄柚-药物相互作用
本研究利用PK-Sim建立葡萄柚中佛手柑内酯(BGT)和6,7-二羟基佛手柑内酯(DHB)的PBPK模型,整合43项临床研究数据,成功模拟了葡萄柚汁与10种CYP3A4底物药物的相互作用,并捕捉了CYP3A4失活的时间依赖性效应及对肠道和肝脏CYP3A4浓度的影响。
要点
- 葡萄柚是CYP3A4的中至强效失活剂,主要活性成分为呋喃香豆素类BGT和DHB。
- 所建PBPK模型能描述葡萄柚汁与10种CYP3A4底物药物的相互作用及主要代谢物。
- 模型可模拟CYP3A4失活的时间依赖性及对肠道和肝脏CYP3A4浓度的影响。
核心结论
- 所建立的BGT和DHB的PBPK模型能成功描述葡萄柚汁与10种CYP3A4底物药物的相互作用,并模拟CYP3A4失活的时间依赖性效应及对肠道和肝脏CYP3A4浓度的影响。
研究设计与样本
- 在PK-Sim中建立葡萄柚模型,并与已公开且经过CYP3A4介导药物相互作用评估的CYP3A4底物PBPK模型耦合。
- 模型开发共使用了43项临床研究数据。
- 建立了佛手柑内酯(BGT)和6,7-二羟基佛手柑内酯(DHB)作为葡萄柚汁中相关活性成分的模型。
主要发现
- 最终模型成功描述了葡萄柚汁成分与10种不同CYP3A4底物药物的相互作用,模拟了CYP3A4失活对底物药物及其主要代谢物药代动力学的影响。
- 模型充分捕捉了CYP3A4失活的时间依赖性效应以及葡萄柚摄入对肠道和肝脏CYP3A4浓度的影响。
关键数值与推荐
- BGT和DHB模型均包含:基于体外参数的CYP3A4失活、模型开发过程中估计的CYP3A4介导清除以及被动肾小球滤过。
临床怎么用
- 该PBPK模型可用于预测葡萄柚汁对各种CYP3A4底物药物血浆浓度-时间曲线的影响,辅助临床评估葡萄柚-药物相互作用风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Grapefruit is a moderate to strong inactivator of CYP3A4, which metabolizes up to 50% of marketed drugs. The inhibitory effect is mainly attributed to furanocoumarins present in the fruit, irreversibly inhibiting preferably intestinal CYP3A4 as suicide inhibitors. Effects on CYP3A4 victim drugs can still be measured up to 24 hours after grapefruit juice (GFJ) consumption. The current study aimed to establish a physiologically-based pharmacokinetic (PBPK) grapefruit-drug interaction model by modeling the relevant CYP3A4 inhibiting ingredients of the fruit to simulate and predict the effect of GFJ consumption on plasma concentration-time profiles of various CYP3A4 victim drugs. The grapefruit model was developed in PK-Sim and coupled with previously developed PBPK models of CYP3A4 substrates that were publicly available and already evaluated for CYP3A4-mediated drug-drug interactions. Overall, 43 clinical studies were used for model development. Models of bergamottin (BGT) and 6,7-dihydroxybergamottin (DHB) as relevant active ingredients in GFJ were established. Both models include: (i) CYP3A4 inactivation informed by in vitro parameters, (ii) a CYP3A4 mediated clearance estimated during model development, as well as (iii) passive glomerular filtration. The final model successfully describes interactions of GFJ ingredients with 10 different CYP3A4 victim drugs, simulating the effect of the CYP3A4 inactivation on the victims' pharmacokinetics as well as their main metabolites. Furthermore, the model sufficiently captures the time-dependent effect of CYP3A4 inactivation as well as the effect of grapefruit ingestion on intestinal and hepatic CYP3A4 concentrations.
引用
- Fuhr LM, Marok FZ, Fuhr U, et al. Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7-Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit-Drug Interactions. Clin Pharmacol Ther. 2023. PMID: 37307228. doi:10.1002/cpt.2968
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。